Novartis lung cancer drug Zykadia(R) recommended for EU approval in patients with ALK+ NSCLC previously treated with crizotinib

… (ALK)-positive advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib … in cancers including non-small cell lung cancer (NSCLC). Zykadia is currently approved … ] American Cancer Society. Detailed Guide: Lung Cancer (Non-Small Cell). Available at http …